Abstract
The aim of this study was to test the contribution of anti-myelin antibodies in predicting conversion from clinically isolated syndrome (CIS) to multiple sclerosis (MS) when considering either Poser's or McDonald's diagnostic criteria. Fifty-one patients with CIS and abnormal brain MRI were imaged monthly for six months and then at 12, 18, 24, 36 months. At baseline serum samples testing antibodies against myelin oligodendrocyte glycoprotein (anti-MOG) and myelin basic protein (anti-MBP) were collected. During the 36-month follow-up, 26 (51%) patients developed a relapse thus becoming clinically definite MS (CDMS) according to Poser's criteria; 46 (90.2%) patients converted to MS according to McDonald's criteria. Out of 51 patients, 28 (54.9%) had either double or single positivity for anti-myelin antibodies. Antibody status significantly predicted MS according to Poser's criteria (P=0.004), but did not according to the McDonald's criteria. When compared to antibody negative patients, the risk of developing a relapse was 8.9 (95% Cl: 2.7-29.8; P
Original language | English |
---|---|
Pages (from-to) | 1086-1094 |
Number of pages | 9 |
Journal | Multiple Sclerosis Journal |
Volume | 13 |
Issue number | 9 |
DOIs | |
Publication status | Published - Nov 2007 |
Keywords
- Clinically isolated syndrome
- MBP antibodies
- MOG antibodies
- MRI
- Multiple sclerosis
- Relapse
ASJC Scopus subject areas
- Clinical Neurology